{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:41:37Z","timestamp":1787755297374,"version":"build-2784847793"},"reference-count":56,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Selection of a suitable donor for allogeneic hematopoietic stem cell transplantation (allo-HCT) has mainly relied on HLA matching and, to date, a matched sibling donor (MSD) remains the first choice. However, patients with acute myeloid leukemia (AML) are older and therefore tend to have older siblings. Haploidentical donors (HIDs) are easily available, and offspring are younger than siblings. As donor age has been associated with worse outcomes, a younger HID might be a better choice than an older MSD for older patients with AML who receive transplantation in first complete remission (CR1). From the European Society for Blood and Marrow Transplantation registry database, we selected patients with AML aged \u226560 years who received transplantation in CR1, either from MSD aged \u226550 years or HID \u226440 years. HIDs received posttransplant cyclophosphamide as graft-versus-host disease (GVHD) prophylaxis, and MSDs received in vivo T-cell depletion. A total of 1247 patients were identified, including 721 MSDs and 526 HIDs. In univariate analysis, HID was associated with lower relapse incidence (P = .01), higher nonrelapse mortality (NRM; P = .01). The 2-year probability of overall survival (OS), leukemia-free survival (LFS), and GVHD-free and relapse-free survival (GRFS) were 62.5%, 56%, and 47%, respectively for the all population. In multivariate analysis, we confirmed that HID was associated with less relapse but more NRM, which translated into similar OS, LFS, and GRFS. Based on this retrospective study, young HIDs led to less relapse but higher NRM than older MSDs after allo-HCT in an older population with AML in CR1.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015582","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T16:19:46Z","timestamp":1752682786000},"page":"5192-5200","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Older matched sibling donor vs young haploidentical donor for older patients with acute myeloid leukemia"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1897-0227","authenticated-orcid":false,"given":"Xavier","family":"Poir\u00e9","sequence":"first","affiliation":[{"name":"1Service d'H\u00e9matologie Adulte, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[{"name":"2Acute Leukemia Working Party of European Society of Blood and Marrow Transplantation, Paris, France"},{"name":"3Universit\u00e9 Pierre et Marie Curie, Paris, France"},{"name":"4Institut National de Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 Mixte de Recherche 938, Paris, France"},{"name":"5Service d\u2019H\u00e9matologie, H\u00f4pital Saint-Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0060-5467","authenticated-orcid":false,"given":"Emmanuelle","family":"Polge","sequence":"additional","affiliation":[{"name":"2Acute Leukemia Working Party of European Society of Blood and Marrow Transplantation, Paris, France"},{"name":"3Universit\u00e9 Pierre et Marie Curie, Paris, France"},{"name":"4Institut National de Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 Mixte de Recherche 938, Paris, France"},{"name":"5Service d\u2019H\u00e9matologie, H\u00f4pital Saint-Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5684-9447","authenticated-orcid":false,"given":"Didier","family":"Blaise","sequence":"additional","affiliation":[{"name":"6Programme de Transplantation and Therapie Cellulaire, Institut Paoli Calmette, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[{"name":"7Service d'H\u00e9matologie, Centre Hospitalier Universitaire de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4257-5980","authenticated-orcid":false,"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"8Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5103-9966","authenticated-orcid":false,"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[{"name":"9Bone Marrow Transplantation Centre, University Hospital Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Besley","sequence":"additional","affiliation":[{"name":"10Department of Hematology, University Hospitals of Bristol and Weston, National Health Service Foundation Trust, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Nguyen","sequence":"additional","affiliation":[{"name":"11Service d'H\u00e9matologie, Universit\u00e9 Paris IV, H\u00f4pital la Piti\u00e9-Salp\u00e9tri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Castilla-Llorente","sequence":"additional","affiliation":[{"name":"12Service d'H\u00e9matologie, Gustave Roussy Cancer Campus, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-7533","authenticated-orcid":false,"given":"G\u00e9rard","family":"Soci\u00e9","sequence":"additional","affiliation":[{"name":"13Bone Marrow Transplantation Unit, Department of Hematology and Bone Marrow Transplantation, H\u00f4pital Saint-Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Forcade","sequence":"additional","affiliation":[{"name":"14Service d'H\u00e9matologie, Centre Hospitalier Universitaire de Bordeaux, H\u00f4pital Haut-Leveque, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8462-6198","authenticated-orcid":false,"given":"Anne","family":"Huynh","sequence":"additional","affiliation":[{"name":"15Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Wolfgang","family":"Blau","sequence":"additional","affiliation":[{"name":"16Department of Hematology, Medizinische Klinik m. S. H\u00e4matologie, Onkologie und Tumorimmunologie, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-1265","authenticated-orcid":false,"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[{"name":"17Department of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6934-4619","authenticated-orcid":false,"given":"Jaime","family":"Sanz","sequence":"additional","affiliation":[{"name":"18Hematology Department, Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"},{"name":"19Centro de Investigacion Biomedica en Red Cancer, Instituto Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Piemontese","sequence":"additional","affiliation":[{"name":"20Division of Hematology, Istituti di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-808X","authenticated-orcid":false,"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[{"name":"2Acute Leukemia Working Party of European Society of Blood and Marrow Transplantation, Paris, France"},{"name":"3Universit\u00e9 Pierre et Marie Curie, Paris, France"},{"name":"4Institut National de Sant\u00e9 et de la Recherche M\u00e9dicale, Unit\u00e9 Mixte de Recherche 938, Paris, France"},{"name":"5Service d\u2019H\u00e9matologie, H\u00f4pital Saint-Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[{"name":"2Acute Leukemia Working Party of European Society of Blood and Marrow Transplantation, Paris, France"},{"name":"20Division of Hematology, Istituti di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"12","key":"2025102809164894900_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"4","key":"2025102809164894900_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jamaoncol.2022.7605","article-title":"Allogeneic hematopoietic cell transplantation vs standard consolidation chemotherapy in patients with intermediate-risk acute myeloid leukemia: a randomized clinical trial","volume":"9","author":"Bornh\u00e4user","year":"2023","journal-title":"JAMA Oncol"},{"issue":"8","key":"2025102809164894900_bib3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3324\/haematol.2018.189258","article-title":"Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"103","author":"Salvatore","year":"2018","journal-title":"Haematologica"},{"issue":"9","key":"2025102809164894900_bib4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2025102809164894900_bib5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2025102809164894900_bib6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/leu.2012.210","article-title":"Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings","volume":"27","author":"Kr\u00f6ger","year":"2013","journal-title":"Leukemia"},{"issue":"13","key":"2025102809164894900_bib7","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1182\/blood-2012-08-453860","article-title":"Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?","volume":"121","author":"Alousi","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2025102809164894900_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3324\/haematol.2017.178251","article-title":"Allogeneic stem cell transplantation benefits for patients \u226560 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"103","author":"Poir\u00e9","year":"2018","journal-title":"Haematologica"},{"issue":"9","key":"2025102809164894900_bib9","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s41375-024-02359-8","article-title":"Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide","volume":"38","author":"Piemontese","year":"2024","journal-title":"Leukemia"},{"issue":"12","key":"2025102809164894900_bib10","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.bbmt.2018.07.022","article-title":"Effect of donor age and donor relatedness on time to allogeneic hematopoietic cell transplantation in acute leukemia","volume":"24","author":"Visram","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2025102809164894900_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-017-0394-2","article-title":"A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia","volume":"10","author":"Piemontese","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"3","key":"2025102809164894900_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial","volume":"137","author":"Fuchs","year":"2021","journal-title":"Blood"},{"issue":"6","key":"2025102809164894900_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41409-018-0126-4","article-title":"Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older","volume":"53","author":"Bashey","year":"2018","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"2025102809164894900_bib14","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bbmt.2018.02.002","article-title":"HLA-matched sibling versus unrelated versus haploidentical related donor allogeneic hematopoietic stem cell transplantation for patients aged over 60 years with acute myeloid leukemia: a single-center donor comparison","volume":"24","author":"Devillier","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"2025102809164894900_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","author":"Gooptu","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2025102809164894900_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3324\/haematol.2018.215202","article-title":"Alternative donor transplantation for acute myeloid leukemia in patients aged \u226550 years: young HLA-matched unrelated or haploidentical donor?","volume":"105","author":"Perales","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"2025102809164894900_bib17","first-page":"6","article-title":"Hematopoietic cell transplantation in the treatment of newly diagnosed adult acute myeloid leukemia: an evidence-based review from the American Society of Transplantation and Cellular Therapy","volume":"27","author":"Dholaria","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"11","key":"2025102809164894900_bib18","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/s41409-024-02400-5","article-title":"Young (&lt;35 years) haploidentical versus old (\u226535 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"59","author":"Nagler","year":"2024","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"2025102809164894900_bib19","first-page":"377.e1","article-title":"Impact of donor age in haploidentical-post-transplantation cyclophosphamide versus matched unrelated donor post-transplantation cyclophosphamide hematopoietic stem cell transplantation in patients with acute myeloid leukemia","volume":"29","author":"Mehta","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"8","key":"2025102809164894900_bib20","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.3390\/curroncol29080470","article-title":"Donor age and non-relapse mortality: study of their association after HLA-matched allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndrome","volume":"29","author":"Kadri","year":"2022","journal-title":"Curr Oncol"},{"issue":"5","key":"2025102809164894900_bib21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjh.17978","article-title":"Effect of donor characteristics on T cell-replete haploidentical stem cell transplantation over the last 10 years at a single institution","volume":"196","author":"Wu","year":"2022","journal-title":"Br J Haematol"},{"issue":"12","key":"2025102809164894900_bib22","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"2025102809164894900_bib23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41409-020-0803-y","article-title":"Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients","volume":"55","author":"Spyridonidis","year":"2020","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"2025102809164894900_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/bmt.2015.305","article-title":"Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission","volume":"51","author":"Ruggeri","year":"2016","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"2025102809164894900_bib25","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"issue":"13","key":"2025102809164894900_bib26","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"issue":"9","key":"2025102809164894900_bib27","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/bloodadvances.2024012669","article-title":"Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes","volume":"8","author":"Mehta","year":"2024","journal-title":"Blood Adv"},{"issue":"5","key":"2025102809164894900_bib28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jca.22066","article-title":"Favorable recovery profiles and good reliability among youngest unrelated stem cell donors supports lowering the minimum donor registration age","volume":"38","author":"Ros-Soto","year":"2023","journal-title":"J Clin Apher"},{"issue":"8","key":"2025102809164894900_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41409-023-01984-8","article-title":"Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation","volume":"58","author":"Pruitt","year":"2023","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"2025102809164894900_bib30","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.bbmt.2019.05.031","article-title":"Who is a better donor for recipients of allogeneic hematopoietic cell transplantation: a young HLA-mismatched haploidentical relative or an older fully HLA-matched sibling or unrelated donor?","volume":"25","author":"Karam","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"2025102809164894900_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00277-020-04359-x","article-title":"Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblings","volume":"100","author":"Ma","year":"2021","journal-title":"Ann Hematol"},{"issue":"17","key":"2025102809164894900_bib32","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1002\/cam4.3290","article-title":"Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: a single-center retrospective study","volume":"9","author":"Huang","year":"2020","journal-title":"Cancer Med"},{"issue":"16","key":"2025102809164894900_bib33","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/bloodadvances.2020001620","article-title":"Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy","volume":"4","author":"Mariotti","year":"2020","journal-title":"Blood Adv"},{"issue":"5271","key":"2025102809164894900_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","article-title":"The aging immune system: primer and prospectus","volume":"273","author":"Miller","year":"1996","journal-title":"Science"},{"issue":"6","key":"2025102809164894900_bib35","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1189\/jlb.0907627","article-title":"The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age","volume":"84","author":"Simone","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"4","key":"2025102809164894900_bib36","first-page":"313.e1","article-title":"Epigenetic aging and hematopoietic cell transplantation in patients with severe aplastic anemia","volume":"27","author":"Alsaggaf","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"8","key":"2025102809164894900_bib37","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.3324\/haematol.2016.160481","article-title":"Dynamics of epigenetic age following hematopoietic stem cell transplantation","volume":"102","author":"St\u00f6lzel","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"2025102809164894900_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbmt.2014.09.021","article-title":"Impact of donor age on outcome after allogeneic hematopoietic cell transplantation","volume":"21","author":"Rezvani","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"2025102809164894900_bib39","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/trf.12612","article-title":"Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study","volume":"54","author":"Bertani","year":"2014","journal-title":"Transfusion"},{"issue":"1","key":"2025102809164894900_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.46989\/001c.92460","article-title":"Supportive care of hematopoietic stem cell donors","volume":"6","author":"Rennert","year":"2024","journal-title":"Clin Hematol Int"},{"issue":"26","key":"2025102809164894900_bib41","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"2025102809164894900_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1200\/JCO.21.02286","article-title":"Donor clonal hematopoiesis and recipient outcomes after transplantation","volume":"40","author":"Gibson","year":"2022","journal-title":"J Clin Oncol"},{"issue":"10","key":"2025102809164894900_bib43","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.2021013443","article-title":"HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide","volume":"139","author":"Fuchs","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2025102809164894900_bib44","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2352-3026(19)30208-X","article-title":"Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study","volume":"7","author":"Petersdorf","year":"2020","journal-title":"Lancet Haematol"},{"issue":"20","key":"2025102809164894900_bib45","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1182\/bloodadvances.2020003110","article-title":"Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide","volume":"4","author":"Solomon","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"2025102809164894900_bib46","first-page":"909.e1","article-title":"Haploidentical versus mismatched unrelated donor hematopoietic cell transplantation: HLA factors and donor age considerations","volume":"30","author":"Mehta","year":"2024","journal-title":"Transpl Cell Ther"},{"issue":"20","key":"2025102809164894900_bib47","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1182\/bloodadvances.2024013853","article-title":"Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations","volume":"8","author":"Mehta","year":"2024","journal-title":"Blood Adv"},{"issue":"6","key":"2025102809164894900_bib48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","article-title":"Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation","volume":"39","author":"Luznik","year":"2012","journal-title":"Semin Oncol"},{"issue":"1","key":"2025102809164894900_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-020-00882-6","article-title":"Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT","volume":"13","author":"Sanz","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2025102809164894900_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41408-024-00990-3","article-title":"Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10\/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial","volume":"14","author":"Brissot","year":"2024","journal-title":"Blood Cancer J"},{"issue":"11","key":"2025102809164894900_bib51","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/bloodadvances.2021005847","article-title":"Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial","volume":"6","author":"Broers","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"2025102809164894900_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.2021015129","article-title":"How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond","volume":"141","author":"Rimando","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2025102809164894900_bib53","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41375-024-02256-0","article-title":"Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis","volume":"38","author":"Ramdial","year":"2024","journal-title":"Leukemia"},{"issue":"10","key":"2025102809164894900_bib54","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/bloodadvances.2023012133","article-title":"Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT","volume":"8","author":"Sanz","year":"2024","journal-title":"Blood Adv"},{"issue":"8","key":"2025102809164894900_bib55","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ajh.26627","article-title":"Human leukocyte antigen-haploidentical transplantation for relapsed\/refractory acute myeloid leukemia: better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients \u226555 years of age","volume":"97","author":"Baron","year":"2022","journal-title":"Am J Hematol"},{"issue":"18","key":"2025102809164894900_bib56","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1002\/cncr.35365","article-title":"Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: a report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party","volume":"130","author":"Bazarbachi","year":"2024","journal-title":"Cancer"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/20\/5192\/2416854\/blooda_adv-2024-015582-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/20\/5192\/2416854\/blooda_adv-2024-015582-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:17:00Z","timestamp":1761657420000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/20\/5192\/546208\/Older-matched-sibling-donor-vs-young"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":56,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,10,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015582","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,28]]},"published":{"date-parts":[[2025,10,16]]}}}